Acknowledgements & Disclosures
The American College of Rheumatology (ACR) is the leading authority and trusted partner of rheumatology professionals.
The ACR believes that collective efforts are essential to advance the quality of patient care and improve outcomes in rheumatology, and that it has mutual goals with external entities including corporations in the pharmaceutical, biotech, and medical device industries. These external entities advance innovation and contribute in meaningful ways to the rheumatology community.
The ACR regularly engages with these external entities in strategic relationships that affirm and support its mission and core values. When structured correctly, the ACR asserts that these relationships can be ethical, positive, and productive.
These strategic relationships are governed by the ACR Guiding Principles for Interactions with External Entities.
Corporate Supporters
The ACR engages in strategic, collaborative initiatives and works closely with external entities, including corporations, in areas of mutual interest that advance the field of rheumatology and add value to the community. The ACR believes these financial relationships should be transparent.
The American College of Rheumatology thanks our corporate supporters for their commitment to advancing rheumatology by supporting the activities of the ACR and ARP. It is through the generous support of our industry colleagues that we can successfully continue our work of providing programs of education, research, and practice support to the rheumatology community.
Thank You to Our Corporate Supporters
State-of-the-Art Clinical Symposium
The ACR thanks Janssen Scientific Affairs, LLC for their unrestricted educational grant in support of the State-of-the-Art Clinical Symposium 2025.
ACR Convergence
Please check back soon for ACR Convergence 2025 supporter disclosures.